Sveriges mest populära poddar
JAMA Clinical Reviews
Hälsa och motionMedicin

Remdesivir and Dexamethasone for the Treatment of COVID-19

36 min•20 juli 2020

Both remdesivir and dexamethasone have been promoted as effective treatments for COVID-19. JAMA Deputy Editor Greg Curfman, MD, and Professor Rachel Sachs, JD, from the Washington University School of Law discuss the science and health policy aspects of these COVID-19 treatments.

Related Article(s):

Missed Opportunities on Emergency Remdesivir Use

Fler avsnitt av JAMA Clinical Reviews

Visa alla avsnitt av JAMA Clinical Reviews
Evaluating for Pediatric Concussion
•16 min
Iron Deficiency in Adults: Advances in Diagnosis and Treatment
•17 min
From the JAMA Network: Incidental Rotator Cuff Abnormalities on Magnetic Resonance Imaging
•15 min
Resistant Hypertension: Diagnosis and Management
•18 min
Update on Peanut Allergy
•19 min
Obesity-Related Cancer
•21 min
Diagnosis and Treatment of Chronic, Noninfectious Diarrhea
•20 min
Does This Patient Have Volume Overload? The Rational Clinical Examination
•19 min
Type 1 Diabetes: Diagnosis and Management
•17 min
Pharmaceutical Pricing: JAMA Talks With Mark Cuban
•33 min

JAMA Clinical Reviews med JAMA Network finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.